Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030 - Rootsanalysis
Roots Analysis has announced the addition of "Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030" report to its list of offerings.
By: Roots Analysis
The development of such biologics is inherently complex, and many drug developers are now seeking to optimize R&D efficiency and affiliated costs. As a result, innovator companies are outsourcing most of their discovery-stage operations to specialty contract research organizations (CROs), which offer a plethora of advanced technologies to cater to the evolving needs. It is also worth highlighting that stakeholders engaged in this domain are actively undertaking initiatives to develop interventions for SARS-CoV-2 virus.
To order this 450+ page report, which features 120+ figures and 140+ tables, please visit this link
Partnership activity within this domain has grown at a CAGR of 18%, between 2015 and 2020
In the last five years, more than 400 agreements were inked related to antibody discovery, with the maximum activity being reported in 2018. Majority of partnership deals signed within this domain were licensing agreements (25%), product development and commercialization agreements (24%), and R&D agreements (18%).
Nearly USD 7 billion has been invested in the antibody discovery domain, during 2016-2020
The aforementioned amount was raised across more than 140 funding instances. It is important to mention that, in 2019-2020, over USD 2 billion was raised by antibody discovery service and platform providers across close to 40 instances. Majority of the funding in this year was acquired through venture capital rounds (42%), grants (20%), and instances of initial public offering (10%).
The antibody discovery services market is anticipated to be worth over USD 6 billion by 2030
For additional details, please visit
or email email@example.com
You may also be interested in the following titles:
1. Antibody Contract Manufacturing Market, 2020 – 2030 (https://www.rootsanalysis.com/
2. Antibody Drug Conjugates Market (5th Edition), 2019-2030
3. Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030
+1 (415) 800 3415